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Synaptic targeting and localization of Discs-large is a stepwise
process controlled by different domains of the protein
U. Thomas*†, S. Ebitsch*†, M. Gorczyca*, Y.H. Koh*, C.D. Hough‡, D. Woods‡,
E.D. Gundelfinger† and V. Budnik*
Background: Membrane-associated guanylate kinases (MAGUKs) assemble ion
channels, cell-adhesion molecules and components of second messenger
cascades into synapses, and are therefore potentially important for co-ordinating
synaptic strength and structure. Here, we have examined the targeting of the
Drosophila MAGUK Discs-large (DLG) to larval neuromuscular junctions.
Results: During development, DLG was first found associated with the muscle
subcortical compartment and plasma membrane, and later was recruited to the
postsynaptic membrane. Using a transgenic approach, we studied how
mutations in various domains of the DLG protein affect DLG targeting. Deletion
of the HOOK region — the region between the Src homology 3 (SH3) domain
and the guanylate-kinase-like (GUK) domain — prevented association of DLG
with the subcortical network and rendered the protein largely diffuse. Loss of
the first two PDZ domains led to the formation of large clusters throughout the
plasma membrane, with scant targeting to the neuromuscular junction. Proper
trafficking of DLG missing the GUK domain depended on the presence of
endogenous DLG.
Conclusions: Postsynaptic targeting of DLG requires a HOOK-dependent
association with extrasynaptic compartments, and interactions mediated by the
first two PDZ domains. The GUK domain routes DLG between compartments,
possibly by interacting with recently identified cytoskeletal-binding partners.
Background
Membrane-associated guanylate kinases (MAGUKs) cluster
ion channels, cell-adhesion molecules (CAMs), cytoskeletal
proteins and components of second messenger cascades,
and are therefore central elements in synaptic architecture
[1,2]. Their ability to bind several proteins is reflected by
their modular structure. The Drosophila MAGUK Discs-
large (DLG) and its mammalian homologs PSD-95, SAP97,
PSD-93 and SAP102 share a modular organization com-
posed of three protein-interaction motifs known as PDZ
domains, followed by a Src homology 3 (SH3) domain and a
guanylate-kinase-like domain (GUK) [2]. 
The PDZ domains bind carboxy-terminal S/TXV motifs
(tS/TXV) [2]. This type of interaction underlies the binding
of Shaker-type potassium channels, N-methyl-D-aspartate
(NMDA) receptor subunits or the Drosophila CAM Fasci-
clin II (FasII) to the first and second PDZ domains (PDZ1
and 2) [3–7]. It also mediates binding of the neurexin
ligand neuroligin, the Rho effector Citron, the Ras-
GTPase-activating protein SynGAP, and the cytoskele-
ton-associated protein CRIPT to the third PDZ (PDZ3)
domain [8–13]. The SH3 domain of PSD-95 has been
implicated in binding kainate receptors [14]. The GUK
domain, which is enzymatically inactive [15], can bind
members of the GKAP/SAPAP family of synaptic proteins
[16,17]. This interaction may link MAGUKs to other
synaptic scaffolding proteins, such as ProSAP (also known
as Shank) and Homer [18–21]. In addition, an interaction
of the GUK domain with microtubule-associated protein-
1a (MAP-1a) suggests a role for this domain in trafficking
of MAGUKs [22]. Different modes of MAGUK oligomer-
ization have been proposed, including head-to-head dimer-
ization and a calmodulin-supported interaction between
the GUK domain and a region carboxy-terminal to the
SH3 domain [23,24]. 
The pivotal role of MAGUKs in synaptic assembly raises
the question of whether they are regulated during synap-
tic plasticity. Such regulation might take place at different
levels, including targeting and localization. Indeed, we
have found that synaptic localization of DLG at larval
neuromuscular junctions (NMJs) is dramatically decreased
by phosphorylation through Ca++/calmodulin-dependent
protein kinase II (CaMKII) [25]. This regulation of DLG
localization may contribute to activity-dependent struc-
tural plasticity. Though CaMKII-dependent DLG phos-
phorylation is important for the local and temporary
regulation of DLG at the synapse, the mechanisms by
which DLG is first targeted to synapses are still unclear.
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Previous studies of the targeting of DLG or SAP97 in
epithelial cells, or targeting of PSD-95 in cultured neurons,
yielded surprisingly disparate results [26–29], suggesting
that cell-type- and/or isoform-specific features are impor-
tant for targeting MAGUKs to cellular junctions. In line
with this idea, some of the regions that were found critical
for targeting — notably the amino termini and the region
between the SH3 and GUK domains (the HOOK region)
[26] — are barely conserved among MAGUKs. Most of
these studies, however, were done in the presence of
endogenous MAGUK, which might affect the targeting
behavior of transgenically expressed isoforms by direct or
indirect interactions. 
To determine which DLG domains are required for post-
synaptic targeting, we expressed various DLG deletion
constructs in muscle and determined their subcellular
localization both in the presence and absence of endoge-
nous DLG. We found that DLG was first directed to a
subcortical network and the muscle membrane, from
where it was targeted to the postsynaptic membrane. In
this two-step process, the HOOK region was required for
the first step, whereas the PDZ1 and 2 domains were
involved in the second. Strikingly, synaptic localization of
a DLG mutant missing the GUK domain depended on
endogenous DLG, providing evidence that the GUK
domain is involved in DLG transport and co-targeting of
DLG molecules in vivo. 
Results
DLG localization at synaptic and extrasynaptic regions
during development
In third instar larval muscles, DLG is concentrated pri-
marily at type I NMJs [30]. Closer examination revealed
evenly distributed, weak immunoreactive spots at the
muscle surface (Figure 1a). In addition, a subcortical
immunoreactive network, localized to the same range of
optical sections as the muscle nuclei, was observed (see
below). Both types of extrasynaptic staining were specific
to DLG as they were not observed in mutant flies that
express extremely low levels of a truncated form of DLG
(dlgX1-2 mutants) [5] (data not shown). 
To determine whether DLG localization at extrasynaptic
regions might represent intermediate trafficking steps, we
analyzed DLG expression in muscles during develop-
ment. Previously, we first observed DLG at presynaptic
termini in stage 17 embryos, whereas DLG localization at
the postsynaptic membrane was not detected before the
first larval instar stage [31]. Here, we used a highly sensi-
tive anti-DLG antibody (anti-DLGPDZ antibody [25]) to
determine the time course of DLG expression at extra-
synaptic regions. In stage 16 embryos, DLG immunoreac-
tivity was apparent in the ventral nerve cord (Figure 2a),
but virtually absent in both presynaptic termini and body
wall muscles (Figure 2b,c). At stage 17, after the initial
formation of synaptic boutons, DLG was detected at sites
of contact between nerves and muscles (Figure 2d,e).
Double labeling with the neuron-specific anti-HRP anti-
body confirmed that this immunoreactivity was presynap-
tic and that DLG was still absent from the postsynaptic
junctional region (Figure 2f). At the same stage, however,
extrasynaptic DLG immunoreactivity became detectable,
both as spots distributed throughout the muscle surface
(Figure 2d) and as a subcortical network (Figure 2e). Thus,
expression of DLG at distinct extrasynaptic sites clearly
precedes its concentration at the postsynaptic membrane.
A continuous shift of DLG immunoreactivity from extrasy-
naptic to synaptic sites was observed during larval devel-
opment. By the first instar stage, when DLG began to
accumulate at the postsynaptic junctional membrane,
extrasynaptic DLG immunoreactivity at both the muscle
membrane and the subcortical network was strong
(Figure 3a,b). By the second instar stage, synaptic DLG
localization was very strong, whereas extrasynaptic DLG
localization was significantly reduced (Figure 3c,d). In
third instar larvae, DLG was almost exclusively localized
at synapses and only little DLG could still be detected at
the surface (Figure 3e) and subcortical region (Figure 3f). 
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Figure 1
DLG expression at body wall muscles of wild-type and UAS–DLG-
expressing flies, and dlg1P20 mutants. The third instar body wall
muscles shown were stained with antibodies directed against
(a,c,d) DLG (anti-DLGPDZ antibody) or (b) the FLAG epitope tag
(anti-FLAG antibody). (a) In wild-type flies, endogenous DLG
immunoreactivity was concentrated at the NMJ, with weak expression
at extrasynaptic regions (arrow). In flies expressing (c) UAS–DLG and
(b) UAS–DLG–FLAG, DLG was concentrated at the NMJ, but was
also prominent at extrasynaptic regions. (d) In dlg1P20 mutants, in
which the last 40 carboxy-terminal amino acids of DLG have been
deleted, expression of endogenous and extrasynaptic DLG was similar
to that in wild-type flies. All the confocal images in this figure were
acquired using the same confocal parameters. The scale bar
represents 17 µm.
(a)
Anti-DLGPDZ Wild type Anti-DLGPDZ UAS–DLG
Anti-FLAG UAS–DLG–FLAG Anti-DLGPDZ dlg1P20
(c)
(b) (d)
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Targeted expression of epitope-tagged DLG variants in
body wall muscles
The developmental analysis suggested a stepwise post-
synaptic targeting of DLG. To determine which domains of
DLG are required for distinct targeting steps, we studied
the subcellular distribution of FLAG-epitope-tagged DLG
deletion variants upon targeted expression in body wall
muscles. For this, we took advantage of the GAL4-UAS
expression system [32], using the GAL4 strain C57 as a
muscle-specific activator. Immunoblot analyses confirmed
that the dlg–FLAG deletion constructs depicted in Figure 4a
were expressed at comparable levels and gave rise to pro-
teins of the appropriate molecular weight (Figure 4b). To
evaluate the possible influence of endogenous DLG on the
localization of transgenic DLG variants, we also targeted
expression of each construct in dlgX1-2 mutants [5,33]. 
In all constructs, the last carboxy-terminal 40 amino acids of
DLG were replaced by the FLAG epitope (Figure 4a; [26]).
The importance of the carboxyl terminus for the synaptic
localization of another MAGUK, PSD-95, is controversial
[28,29]. Several observations demonstrated, however, that
carboxy-terminal FLAG tagging has no detectable effect on
the subcellular localization of DLG (Figure 1). The hypo-
morphic allele dlg1P20 gives rise to a truncated protein
lacking the same carboxy-terminal amino aids [33]. The dis-
tribution of this gene product appeared indistinguishable
from the wild type (Figure 1a,d). Upon targeted expression
in muscles, DLG–FLAG became enriched postsynaptically
around type I boutons (Figure 1b). Prominent FLAG
immunoreactivity was also detected extrasynaptically at
both the surface and the subcortical network (Figure 1b;
a three-dimensional projection of confocal slices can
be found at http://www.bio.umass.edu/biology/budnik
[DLGFLAG.tif]). The extrasynaptic immunoreactivity in
DLG–FLAG-expressing flies was clearly stronger than in
the wild type (compare Figure 1a and b). However, a very
similar increase in extrasynaptic immunoreactivity was
observed upon expression of transgenic, non-tagged DLG
with an intact carboxyl terminus (Figure 1c, [34]). This sug-
gests that overexpression per se rather than the carboxy-ter-
minal truncation is responsible for increased extrasynaptic
localization of DLG–FLAG.
The amino terminus of DLG is not required for synaptic
localization
The sequence preceding PDZ1 exhibits only weak or no
homology between various MAGUKs. Several studies
have implicated the amino terminus of both PSD-95 and
SAP97 in junctional targeting [27,28,35,36]. To determine
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Figure 2
(a) Anti-DLGPDZ Anti-HRP
Anti-DLGPDZ
Anti-HRP
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Developmental expression of synaptic and extrasynaptic DLG at body
wall muscles of embryos. (a–c) Stage 16 (a) embryonic nervous
system and (b,c) body wall muscles labeled with (a,b) anti-DLGPDZ or
(c) anti-horseradish peroxidase (HRP) antibodies. (b,c) Same views of
a preparation that was double-labeled. At this stage, DLG was
concentrated in the central nervous system, and absent from muscles
and synaptic terminals. (d–f) Stage 17 embryonic body wall muscles
stained with anti-DLGPDZ antibody. (d,e) Single confocal slices taken
(d) at the surface of the muscles and (e) at the level of the muscle
nuclei. (f) Same view as (e), but double-stained with anti-HRP antibody
to visualize the presynaptic aspect of the NMJ (arrow). Insets in
(d,e) are high-magnification views of the extrasynaptic signal. At this
stage of development, DLG appeared (f) at the presynaptic region, as
well as (d) in a punctate pattern at the muscle surface and (e) in an
intracellular network. The scale bar represents 28 µm, except in the
insets where it represents 7 µm.
whether the amino terminus of DLG is of similar impor-
tance, we expressed transgenic DLG missing the amino ter-
minus (∆N). This construct exhibited a synaptic localization
(Figure 5a) indistinguishable from the control (DLG–FLAG,
Figure 1a). This result was found both when ∆N was
expressed in the presence (Figure 5a) or absence (in dlgX1-2
mutants, data not shown) of endogenous DLG. 
PDZ1 or 2 are required for synaptic but not plasma
membrane targeting
In both the wild type and dlg mutant background, deletion
of any single PDZ domain did not affect the synaptic
localization of DLG (Figure 5a). Deletion of PDZ3 in
combination with either PDZ1 or PDZ2 also did not affect
Research Paper  Synaptic targeting and localization of DLG Thomas et al. 1111
Figure 4
Expression of FLAG-tagged DLG constructs. (a) Diagrammatic
representation of the control (DLG–FLAG) and deletion constructs.
The top diagram is a representation of the modular structure of DLG.
The numbers in each line represent the amino acids immediately
adjacent to the deletions. N, amino terminus; C, carboxyl terminus.
(b) Western blot analyses of body wall muscle extracts from larvae
expressing DLG constructs. Left, anti-DLGPDZ antibodies were used to
detect the transgenic proteins in a dlgX1-2 mutant background. Right,
anti-FLAG antibody was used to detect those variants that lacked
partially or completely the epitopes for anti-DLGPDZ antibody, that is,
the PDZ1 and 2 domains. Asterisks represent extracts of dlgX1-2 body
wall muscles expressing the deletion constructs. All other lanes
represent wild-type body wall muscle extracts expressing the deletion
constructs. Numbers on the left represent molecular weight in kDa.
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Developmental expression of synaptic and extrasynaptic DLG
localization at body wall muscles of larvae. Anti-DLGPDZ antibody
immunoreactivity at body wall muscles of (a,b) first, (c,d) second,
and (e,f) third instar larvae. (a,c,e) Single confocal slices at the
surface of the muscles. (b,d,f) Single confocal slices at the level of
the muscle nuclei. Insets in (a,b) are high-magnification views of
extrasynaptic DLG. In first instar larvae, extrasynaptic DLG was still
very prominent both at the muscle surface and intracellular network.
Extrasynaptic immunoreactivity was very weak in the third instar
stage. All confocal images were acquired using the same confocal
parameters. The scale bar represents 28 µm, except in the insets
where it represents 7 µm.
localization. In contrast, deletion of both PDZ1 and PDZ2
(∆PDZ1 + 2) had dramatic effects on localization. This
variant became localized at the surface of the muscle,
with little synaptic localization (Figure 5b; see also
http://www.bio.umass.edu/biology/budnik [deltaPDZ1-2.tif]).
The immunoreactivity at the plasma membrane appeared
as large spots or clusters distributed throughout the
muscle membrane. The ∆PDZ1 + 2 variant could also be
detected at the subcortical network, although the intensity
of FLAG immunoreactivity was significantly weaker than
in DLG–FLAG-expressing muscles (Figure 5b; middle
panel). Thus, in the absence of PDZ1 and 2, DLG
becomes transported to the muscle membrane, but fails to
be directed to synaptic sites, and instead accumulates in
ectopic clusters. This conclusion was reached by express-
ing ∆PDZ1 + 2 in both the wild type and in dlgX1-2
mutants. To determine whether the distribution of endoge-
nous DLG was altered by the presence of these ectopic
clusters, we performed double labeling experiments in
which ∆PDZ1 + 2 and endogenous DLG proteins were
discriminated using anti-DLGGUK (Figure 6a,c) or anti-
DLGPDZ (Figure 6b,d) antibodies. The anti-DLGGUK
antibody recognizes both endogenous and transgenic
DLG, but the anti-DLGPDZ antibody does not recognize
∆PDZ1 + 2 (Figure 6b). Notably, endogenous DLG did
not become trapped in clusters containing the ∆PDZ1 + 2
variant, but remained synaptically localized (Figure 6d). 
Interestingly a transgenic protein comprising the amino ter-
minus and all three PDZ domains (∆C1/2, Figure 4a) failed to
localize to the plasma membrane or synapses, and was instead
found highly enriched in nuclei and cytoplasm (Figure 5e
and http://www.bio.umass.edu/biology/budnik [deltaC12.tif]).
This result indicates that the PDZ1 and 2 domains are neces-
sary but not sufficient for synaptic targeting.
So far, the Shaker potassium channel and FasII are the
only synaptic proteins that have been reported to bind
PDZ1 and 2 domains of DLG. Synaptic DLG localization
remains largely unaffected by mutations that abolish the
PDZ-binding motif of Shaker or which dramatically
reduce the level of FasII [5–7]. We therefore generated
fasIIe76 Sh102 double mutants to test whether simultaneous
loss of both binding partners affects DLG localization at
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Figure 5
Localization of DLG–FLAG deletion
constructs in body wall muscles when
expressed in a wild-type background. Left and
middle columns are single confocal slices at
the surface (left) and at the level of muscle
nuclei (middle) of third instar body wall
muscles stained with anti-FLAG antibodies.
The right column is a diagrammatic
representation of the distribution of FLAG
immunoreactivity at different muscle sites,
depicted at right angles to the plane of
section of the micrographs. N, nucleus; SR,
sarcoplasmic reticulum; SSR, subsynaptic
reticulum; b, bouton; m, membrane. Listed on
the right of the column are the names of
constructs with similar patterns of FLAG
distribution. (a) FLAG immunoreactivity in the
DLG–FLAG control, which was similar to the
immunoreactivity pattern observed for ∆N,
∆PDZ1, ∆PDZ2, ∆PDZ3, ∆PDZ1 + 3,
∆PDZ2 + 3, and ∆SH3. The arrowhead points
to a segment of the immunoreactive
subcortical network. (b) Localization of
∆PDZ1 + 2 to membrane-associated ectopic
clusters (arrowhead). Note the severe
reduction of immunoreactivity in boutons and
subcortical area. (c) Nuclear, synaptic,
cytoplasmic and membrane localization of
∆HOOK, which was similar to the localization
of ∆E–F. (d) Weak synaptic and membrane
localization of ∆GUK, which was similar to ∆I3
localization. (e) Nuclear and cytoplasmic
localization of ∆C1/2. All confocal images
were acquired using the same parameters.
The scale bar represents 40 µm.
(a)
(c)
(b)
(d)
(e)
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NMJs or even mimics the effect of deleting the PDZ1 and
2 domains. DLG-specific immunofluorescence appeared
largely normal in these double mutants (data not shown). 
The SH3 domain is not involved in synaptic targeting 
The involvement of the SH3 domain in synaptic targeting
of MAGUKs has been controversial [28,29]. To determine
the role of the SH3 domain in DLG targeting, we tested
both the allele dlgm30, in which the SH3 domain is affected
by a point mutation [33], and flies expressing a DLG
variant in which the SH3 domain was deleted (∆SH3). In
both dlgm30 and ∆SH3 flies, DLG was normally targeted to
synaptic sites (Figure 5a). In the case of the ∆SH3 line,
similar results were obtained in the presence and absence
of endogenous DLG. 
The HOOK region is required for plasma membrane
targeting but not association to the membrane
The HOOK region (Figure 4) has been implicated in the
association of DLG with septate junctions in epithelial
cells [26]. This domain is among the least conserved
regions of MAGUKs, but two sub-regions are moderately
conserved among specific subsets of MAGUKs. A band
4.1-binding motif known as I3 is also found in SAP97,
PSD-93 and p55 and may link these MAGUKs to the
actin/spectrin cytoskeleton [37,38]. Another short stretch
(E–F region), presumed to form an α-helix at the amino
terminus of the HOOK region, is found in all DLG-like
MAGUKs, and has been implicated in calmodulin-depen-
dent dimerization of PSD-95 and SAP102 [24].
Deletion of the entire HOOK region (∆HOOK) dramati-
cally affected the synaptic localization of DLG both in the
presence and absence of endogenous DLG (Figure 5c; see
also http://www.bio.umass.edu/biology/budnik [delta-
HOOK.tif]). In general, some synaptic localization was
observed, although weaker than in DLG–FLAG controls.
In addition, the FLAG signal appeared in the muscle
nuclei and throughout the cytoplasm. Extrasynaptic local-
ization at the plasma membrane was weak compared
with DLG–FLAG controls, and virtually no specific
immunoreactivity was detected at the subcortical network
(Figure 5c). The relative intensity of the signals at
synapses versus nuclei varied, even at the muscles within
the same sample. Strikingly, very similar results were
obtained when the amino-terminal helix within the
HOOK region was disrupted by deleting only 13 amino
acids (∆E–F, Figure 4c). Deletion of the I3 region (∆I3)
also resulted in weak synaptic localization of the trans-
genic protein when expressed in wild type (Figure 5d).
Unlike ∆HOOK and ∆E-F, however, deletion of I3 did
not result in nuclear localization. Surprisingly, ∆I3 exhib-
ited strong synaptic localization when expressed in dlgX1-2
mutants (Figure 7c). 
The GUK domain is required for synaptic targeting
The role of the GUK domain in MAGUKs has remained
obscure. In the case of fly epithelial cells, deletion of the
Figure 7
FLAG localization in dlgX1-2 mutants
expressing (a) DLG–FLAG, (b) ∆GUK, and
(c) ∆I3. Unlike the situation in the wild type,
the ∆GUK protein failed to localize at
synapses in the mutant background, whereas
the ∆I3 protein showed an increased
localization to synapses. The scale bar
represents 35 µm.
(a) (c)(b)
   Current Biology
DLG–FLAG dlgx1-2 ∆GUK dlgx1-2 ∆l3 dlgx1-2
Figure 6
Distribution of endogenous DLG in flies expressing the ∆PDZ1 + 2
variant. (a) Anti-DLGGUK antibody immunoreactivity in dlgX1-2 body wall
muscles expressing ∆PDZ1 + 2. (b) Anti-DLGPDZ antibody
immunoreactivity in the same preparation as in (a). Note that the anti-
DLGPDZ antibody used (which was directed against the PDZ1 and 2
domains) does not recognize the ∆PDZ1 + 2 protein. (c) Anti-DLGGUK
antibody immunoreactivity in wild-type flies expressing ∆PDZ1 + 2.
Both endogenous and transgenic protein were labeled by this
antibody. (d) Anti-DLGPDZ antibody immunoreactivity in the same
preparation as in (c), showing that the presence of extrasynaptic
clusters to which ∆PDZ1 + 2 was localized did not affect the
distribution of endogenous DLG. The scale bar represents 42 µm.
(a) (c)
(b) (d)
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GUK domain does not alter localization of DLG to septate
junctions [26]. Various cytoskeletal and synapse-associated
proteins have been reported to bind to the GUK domain
of mammalian MAGUKs, suggesting that this domain may
be important for synaptic localization [16,17,22,39]. To
ascertain the role of GUK in synaptic targeting, we exam-
ined transgenic flies expressing a DLG variant lacking the
GUK domain (∆GUK). In the presence of endogenous
DLG, ∆GUK became localized to synaptic sites, although
this synaptic expression appeared consistently weaker
than in DLG–FLAG-expressing controls (Figure 5d and
http://www.bio.umass.edu/biology/budnik [deltaGUK.tif]).
Notably, however, synaptic localization of ∆GUK was
barely or not detectable upon expression in dlgX1-2 mutants
(Figure 7b). We therefore conclude that endogenous
DLG mediates synaptic targeting of the ∆GUK variant. 
Discussion
Postsynaptic DLG trafficking to NMJs comprises at least
three locations: an intracellular subcortical network, the
plasma membrane, and the synaptic membrane (Figure 8).
In late embryos, DLG was clearly detected at the subcor-
tical network and extrasynaptically at the plasma mem-
brane before becoming localized postsynaptically. The
identity of the subcortical compartment remains elusive
but its network-like appearance suggests that it represents
an extensive membranous structure such as the sarcoplas-
mic reticulum. Interestingly, El-Husseini et al. [40] have
documented that the membrane localization of PSD-95 is
preceded by transient association of the protein with intra-
cellular membranes, for example, a perinuclear endosomal
compartment or the smooth endoplasmic reticulum in
dendritic spines. Similarly, GRIP1, another synaptic scaf-
folding molecule, is also found at intracellular vesicular
structures [41].
Deletions affecting DLG localization at extrasynaptic sites
(for example, ∆HOOK, ∆PDZ1 + 2) also decreased synap-
tic DLG. This observation argues against independent
targeting to different subcellular compartments and led us
to propose that the stepwise trafficking observed in early
development also occurs at later stages. The DLG target-
ing route described here is reminiscent of that of gluta-
mate receptors and a CD8–Shaker fusion protein in
Drosophila, which also become distributed throughout the
muscle membrane before synaptic enrichment [7,42,43].
Our deletion analysis allowed us to relate individual
domains of DLG to particular targeting steps (Figure 8).
We found that the first two PDZ domains, the HOOK
region and the GUK domain contributed to synaptic tar-
geting of DLG differently. The HOOK region was
required for entry into the normal targeting route through
the subcortical network. In contrast to observations on
epithelia, where ∆HOOK was found to be exclusively
nuclear [26], synaptic localization of ∆HOOK was not com-
pletely impaired. This suggests that the protein can still
reach the synapse, perhaps by diffusion, and that other
domains then mediate its localization. The importance of
the HOOK region for targeting to both septate and synap-
tic junctions appears surprising, because it is not well con-
served among MAGUKs. Nevertheless, a short stretch of
amino acids at the amino terminus of the HOOK region of
all DLG-like MAGUKs is predicted to form an α-helix
with a cluster of basic residues on one side. This helix has
been reported to mediate a calmodulin-dependent dimer-
ization of PSD-95 and SAP102 [24]. Our finding, that dis-
ruption of this helix mimics the effect of the entire
∆HOOK deletion, confirms that it is of particular impor-
tance in vivo. It remains to be determined whether it func-
tions in synaptic targeting by promoting dimerization of
DLG, by contributing to an intramolecular interaction
[44], and/or by mediating heterophilic interactions. 
The I3 region within the HOOK domain has been sug-
gested to link MAGUKs to the actin/spectrin cytoskeleton
through binding to protein 4.1 [37,38]. We found that the
∆I3 protein had a stronger synaptic localization when
expressed in dlgX1-2 mutants. An interpretation of this
result is that endogenous DLG competes out ∆I3 protein
in its binding to the synaptic cytoskeleton. 
None of our deletions resulted in an obvious accumulation
solely at the subcortical network. This suggests that no
additional domains are required to leave this compart-
ment. Our findings support a role for the GUK domain to
direct subsequent transport. Recent evidence suggests
1114 Current Biology Vol 10 No 18
Figure 8
DLG targeting to synapses is a stepwise process that requires multiple
domains. The deletion analysis supports a model in which the HOOK
region mediates direct or indirect association of DLG with an
intracellular membrane compartment (1), presumably the sarcoplasmic
reticulum, from which DLG is transported to the muscle plasma
membrane (2 and 3). This transport may involve the association of
vesicle-bound DLG with microtubules and/or a motor protein, as has
been suggested for other MAGUKs [22,40]. In a process that requires
the PDZ1 and 2 domains, DLG is then recruited to the subsynaptic
reticulum (SSR).
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that targeting of PSD-95 and PSD-93 involves a micro-
tubule-dependent transport of vesiculo-tubular structures
[22,40]. These MAGUKs can be linked to microtubules
by binding of the PDZ3 and GUK domains to the micro-
tubule-associated proteins CRIPT or MAP1A, respec-
tively [11,22,45]. Although these binding partners are
suggestive for a role of these domains in MAGUK traffick-
ing, no such function could be unraveled previously
[26–29]. Removal of PDZ3 had no obvious effect on
synaptic localization of DLG. Synaptic localization of the
∆GUK protein was, however, diminished in wild-type
flies and virtually abolished in dlgX1-2 mutants. This
dependency on endogenous DLG might be explained by
dimerization, in agreement with the studies of Masuko
et al. [24]. Alternatively, endogenous DLG could promote
vesiculo-tubular trafficking (Figure 8) [40] and thus allow
the truncated version to hitchhike on the same vesicles.
This explanation would also apply to the finding that the
GUK domain was dispensable for targeting of PSD-95 in
cultured neurons or slices, in which the endogenous
MAGUK is expressed [28,29]. 
Consistent with other studies of MAGUK targeting
[26–29], we found that the PDZ domains were neither
sufficient to target DLG to specific extrasynaptic sites nor
to dock the protein at the synapse. Nonetheless, the
PDZ1 and 2 domains were found to contribute to synaptic
targeting. We suggest that the PDZ1 or PDZ2 domain is
required for the final step in DLG targeting, from plasma
membrane to synapses, but is not necessary to direct DLG
to the plasma membrane (Figure 8). Thus, it may be
assumed that the interaction with at least one PDZ
binding protein is required to transport the protein to the
synapse. A double mutant, in which the only known
binding partners for the PDZ1 and 2 domains of DLG,
Shaker and FasII were abolished or dramatically reduced,
had no obvious effect on synaptic targeting of DLG. Inter-
estingly, a non-synaptic PDZ-binding protein, Cypin, may
regulate synaptic targeting of PSD-95 and SAP102 at
extrasynaptic sites [46]. 
It remains to be determined whether the association of
DLG with intracellular membrane compartments serves
solely to target DLG itself. As discussed for GRIP1 and
PSD-95, this step could also contribute to the sorting and
co-transport of other synaptic molecules such as ion chan-
nels [40,41]. The pre-formation of a junctional protein
complex at intracellular compartments has been exempli-
fied by the interaction of E-cadherin and β-catenin at the
endoplasmic reticulum [47]. The clustering of glycine
receptors by gephyrin provides a contrary example,
however, as gephyrin traps receptor molecules only at
developing synapses [48]. Unfortunately, the limited sen-
sitivity of available Shaker-specific antibodies has
impaired our attempts to distinguish between intracellular
and synaptic assembly of the DLG–Shaker complex. It
appears obvious, however, that each targeting step repre-
sents an additional site at which the molecular composi-
tion of synaptic junctions could be regulated.
Conclusions
DLG-like MAGUKs are highly enriched at glutamatergic
synapses in mammals and insects. The postsynaptic accu-
mulation of DLG at the fly NMJ is based on a targeting
mechanism that includes the temporary association of the
protein with extrasynaptic compartments before its recruit-
ment to the synapse. The HOOK region mediates the
association of DLG with an extensive subcortical network,
presumably the sarcoplasmic reticulum. DLG may reach
the plasma membrane at any point. The first and second
PDZ domains promote the subsequent transport to the
synapse. Despite the identification of various binding part-
ners, the role of the GUK domain of DLG-like MAGUKs
in vivo has remained obscure. We have now unraveled an
essential role for the GUK domain in synaptic targeting,
which is concealed in the presence of endogenous DLG. 
Materials and methods
Flies 
Flies were kept at 25°C on standard medium. The following dlg
mutants were used: y w sn dlgXI-2/Basc, y w f dlg1P20/Basc and y w
dlgm30/Basc. UAS strains were described in [26] or generated as
described below. For expression in a dlg mutant background, females
from y w sn dlgXI-2/Basc; C57/C57 were crossed to UAS target
males. The dlgXI-2 mutant progeny were identified using the y marker
and tumorous imaginal discs. The fasIIe76 Sh102 flies were generated by
meiotic crossover. The presence of Sh102 was confirmed by ether-
induced leg shaking, whereas fasIIe76 was identified by allele-specific
restriction fragment length polymorphisms.
Constructs
The ExSite mutagenesis kit (Stratagene) was employed to generate the
deletions ∆N, ∆I3 and ∆E–F on a dlg cDNA [26]. Mutated subclones
were verified by sequencing. A sequence encoding the FLAG epitope fol-
lowed by a stop codon was cloned in-frame between the EcoRI and BglII
sites at base pairs 2755 and 2804, respectively [26,49]. For germ-line
transformation, the cDNAs were cloned into the pUAST vector [32,50]. 
Body wall preparations, antibodies, and immunofluorescence
Dissections were performed as described [51]. For detection of FLAG-
tagged DLG variants, body walls were fixed for 25 min in 4%
paraformaldehyde, washed 3 × 15 min in PBS containing 0.2% triton
X-100 (PBST). Monoclonal anti-FLAG antibody (M2; Sigma, 1:1000 in
PBST) was applied for 2 h at room temperature. Samples were
washed, incubated with FITC-conjugated donkey anti-mouse IgG
(Jackson Laboratories) at 1:160 (2 h, room temperature), washed and
mounted in Vectashield medium (Vector). A GUK-domain-specific poly-
clonal serum (anti-DLGGUK) was obtained from a rat immunized with an
affinity-purified Histidine-tagged fusion protein comprising amino acids
849–960 of DLG. Specificity of this serum was confirmed by the lack
of immunoreactivity in dlgv59 mutants. This serum was applied overnight
at 4°C at 1:100 on body walls fixed in Bouin’s fixative for 30 min. Anti-
DLGPDZ antibody was used as in [25]. For double labeling, Texas-Red-
conjugated goat anti-HRP antibodies (Jackson Laboratories) were
used at 1:100. Confocal imaging was performed using a BioRad MRC
600 Laser attached to a Nikon microscope. Z-series were taken at
0.1 µm steps for Figures 1,2,5,7 and at 0.3 µm for all others. Samples
selected for direct comparison were scanned with identical confocal
settings. Images were manipulated (Z-series projection, cropping,
analysis of confocal slices) using the NIH Image program (version 1.62).
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Developmental analysis
Late embryos were mechanically dechorionated, devitellinized and fil-
leted using sharpened tungsten needles. Initial staging of embryos was
based on the degree of midgut development [52]. First instar larvae
were dissected shortly after hatching; second instar larvae were
selected based on defined egg-laying intervals, size, and appearance
of anterior spiracles.
Immunoblot analyses
For each genotype, body walls from 10 third instar larvae were trans-
ferred to pre-cooled homogenizers, frozen at –70°C and homogenized
upon addition of 52.5 µl RIPA buffer containing 2 mM PMSF, 1 µg/ml
leupeptin, 1 µg/ml aprotinin; 7.5 µl 1 M DTT was added and the
homogenate centrifuged for 5 min at 3,000 rpm at 4°C. SDS-protein
sample buffer (15 µl of 5× stock) was added to the supernatants and
boiled for 7 min; 15 µl of the protein samples was separated on 8%
polyacrylamide gels and blotted onto Immobilon-P transfer membrane
(Millipore). The membrane was blocked for 1 h at room temperature in
PBS-containing 0.05% Tween, 10% horse serum, 1% goat serum, 3%
BSA and 2mM NaN3. Primary antibodies were used at 1:1,000 (anti-
FLAG) or 1:10,000 (anti-DLGPDZ). HRP-conjugated secondary anti-
bodies were used at 1:3,000. Immunoreactive bands were detected
using the ECL chemoluminescence kit (Amersham).
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